Another great example of how CLDNs’ effects are variable in different cancers is how CLDN6 promotes the EMT in gastric cancer [178] while its downregulation in breast cancer promotes cancer invasiveness and progression [179]. The gene discussed is CLDN6; the disease is cancer.